Pharming Group guidance cut and half year results draw investor focus Pharming Group (ENXTAM:PHARM) has drawn fresh attention after lowering its 2026 revenue guidance by US$30 million and reporting half year 2026 results that showed reduced sales but a smaller net loss. See our latest analysis for Pharming Group. Pharming Group’s guidance cut and half year 2026 results appear to have fed into weaker sentiment, with the stock’s share price down 26.76% over 30 days and a 1 year total...

Pharming Group (PHGUF) navigates a mixed quarter with strong Joenja growth and cost discipline, offset by Ruconest revenue declines and a lowered full-year outlook.

Pharming Group (NASDAQ:PHAR) reported second-quarter revenue of $90.2 million, down 3% from a year earlier, as growth from its Joenja treatment partly offset lower sales of hereditary angioedema therapy RUCONEST. The company reduced its full-year revenue outlook by $30 million but said it expects RU

Even though Pharming Group N.V. ( AMS:PHARM ) posted strong earnings, investors appeared to be underwhelmed. We did...

Shareholders in Pharming Group N.V. ( AMS:PHARM ) had a terrible week, as shares crashed 23% to €1.10 in the week since...

Pharming Group (NASDAQ:PHAR) executives said first-quarter 2026 results reflected an expected decline in RUCONEST revenue tied largely to specialty pharmacy inventory movements and the company’s planned exit from certain non-U.S. markets, while Joenja continued to post strong growth and the company

As global markets navigate the complexities of geopolitical tensions and shifting monetary policies, U.S. stocks have shown resilience with major indexes posting gains despite a hawkish Federal Reserve stance and fluctuating oil prices. In this context, identifying high-growth tech stocks involves looking for companies that demonstrate robust earnings potential and innovation in sectors like artificial intelligence, which are poised to benefit from current market dynamics.

European markets have recently seen a boost in investor sentiment, with the pan-European STOXX Europe 600 Index climbing over 3% following a temporary ceasefire between the U.S. and Iran. Amid these developments, investors are increasingly exploring diverse opportunities to navigate potential economic challenges, including rising inflation and growth forecast adjustments by the EU. Penny stocks, despite their somewhat outdated moniker, continue to attract attention for their potential value;...